Guided Therapeutics Inc. provided sales guidance for the second quarter of 2014 and full year 2014. For the second quarter of 2014, the company expected reporting that sales of LuViva reached $200,000, up over 60% from first quarter results.

The company announced in line with expectations of LuViva sales of $1.0 million to $3.0 million for the full year 2014.